CD177 and chronic myelogenous leukemia, BCR-ABL1 positive: Our results showed that AML and CML differ in the expression of GBF1, CD177, OLFM4 and peptidylprolyl isomerase B (PPIB) implicated in the intercellular interactions and chemotaxis regulation to regulate tumor cell migration and invasion [67,85,86,91,92,93,94,95].